- Home
- MANU vs IMVT Comparison
MANU vs IMVT Comparison
Compare MANU & IMVT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MANU
- IMVT
- Stock Information
- Founded
- MANU 1878
- IMVT N/A
- Country
- MANU United Kingdom
- IMVT United States
- Employees
- MANU N/A
- IMVT N/A
- Industry
- MANU Services-Misc. Amusement & Recreation
- IMVT Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- MANU Consumer Discretionary
- IMVT Health Care
- Exchange
- MANU Nasdaq
- IMVT Nasdaq
- Market Cap
- MANU 2.2B
- IMVT 2.5B
- IPO Year
- MANU 2012
- IMVT N/A
- Fundamental
- Price
- MANU $14.18
- IMVT $14.89
- Analyst Decision
- MANU Buy
- IMVT Buy
- Analyst Count
- MANU 2
- IMVT 10
- Target Price
- MANU $20.75
- IMVT $40.14
- AVG Volume (30 Days)
- MANU 262.2K
- IMVT 1.2M
- Earning Date
- MANU 06-06-2025
- IMVT 05-29-2025
- Dividend Yield
- MANU N/A
- IMVT N/A
- EPS Growth
- MANU N/A
- IMVT N/A
- EPS
- MANU N/A
- IMVT N/A
- Revenue
- MANU $777,029,683.00
- IMVT N/A
- Revenue This Year
- MANU $2.44
- IMVT $108.88
- Revenue Next Year
- MANU $3.82
- IMVT N/A
- P/E Ratio
- MANU N/A
- IMVT N/A
- Revenue Growth
- MANU N/A
- IMVT N/A
- 52 Week Low
- MANU $12.05
- IMVT $12.72
- 52 Week High
- MANU $18.42
- IMVT $34.47
- Technical
- Relative Strength Index (RSI)
- MANU 52.74
- IMVT 50.82
- Support Level
- MANU $13.22
- IMVT $13.79
- Resistance Level
- MANU $14.18
- IMVT $15.22
- Average True Range (ATR)
- MANU 0.43
- IMVT 0.69
- MACD
- MANU -0.01
- IMVT 0.14
- Stochastic Oscillator
- MANU 58.18
- IMVT 75.00
About MANU Manchester United Ltd.
Manchester United PLC operates a professional football club together with related and ancillary activities. The company manages the soccer team and all affiliated club activities of the Manchester United Football Club, which includes the media network, foundation, fan zone, news, and sports features, and team merchandise. Manchester United is based in England. The company has three principal sectors from which the majority of the revenue is generated including Commercial, Broadcasting, and Matchday.
About IMVT Immunovant Inc.
Immunovant Inc is a clinical-stage biopharmaceutical company. It is focused on enabling normal lives for patients with autoimmune diseases. The company's product includes batoclimab and IMVT-1402 targets the neonatal Fc receptor (FcRn).